Grant Skrepnek to Proportional Hazards Models
This is a "connection" page, showing publications Grant Skrepnek has written about Proportional Hazards Models.
Connection Strength
0.040
-
Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs. J Med Econ. 2013; 16(1):10-8.
Score: 0.024
-
Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007 Jan-Feb; 20(1):72-80.
Score: 0.016